IRLAB Therapeutics AB (publ) (STO: IRLAB.A)

IRLAB Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	94	53	32	39.9	32.8	38.7
Cash & Short-Term Investments	94	53	32	39.9	32.8	38.7
Cash Growth	2.17%	65.63%	-19.80%	21.65%	-15.25%	-64.43%
Accounts Receivable	163	118	139	144.9	126.1	151.6
Other Receivables	32	24	18	13.9	7.7	19.1
Receivables	195	142	157	158.8	133.8	170.7
Inventory	322	338	423	267.8	169.3	192.3
Prepaid Expenses	-	4	4	3.8	3.2	3.2
Other Current Assets	-	64	-	1.5	1.5	1.4
Total Current Assets	611	601	616	471.8	340.6	406.3
Property, Plant & Equipment	388	317	365	239.5	247.6	274.8
Long-Term Investments	-	-	-	1.3	1.2	1.4
Goodwill	359	345	363	216.4	29.4	30.3
Other Intangible Assets	57	-	-	42.1	-	-
Long-Term Deferred Tax Assets	-	-	-	-	3.3	0.5
Long-Term Deferred Charges	-	60	79	-	15.4	12.8
Other Long-Term Assets	-	10	16	12.8	31.6	75.5
Total Assets	1,415	1,333	1,439	983.9	669.1	801.6
Accounts Payable	114	60	103	101.3	48.9	55.7
Accrued Expenses	-	34	45	47.5	41.5	20.7
Short-Term Debt	-	-	-	4.8	-	-
Current Portion of Long-Term Debt	-	18	30	61.5	1.2	1.3
Current Portion of Leases	-	24	22	19.6	21.5	24.9
Current Income Taxes Payable	-	-	-	16.7	1.3	2.9
Other Current Liabilities	-	78	135	65.8	36.6	49
Total Current Liabilities	114	214	335	317.2	151	154.5
Long-Term Debt	371	320	318	2.2	3.5	95.4
Long-Term Leases	67	55	53	28.5	22.9	45.2
Long-Term Deferred Tax Liabilities	-	22	20	-	-	-
Other Long-Term Liabilities	213	79	105	96.3	7.9	10.5
Total Liabilities	765	690	831	444.2	198.4	320.8
Common Stock	650	273	273	273.3	273.3	273.3
Retained Earnings	-	355	326	276.2	219.5	220.4
Comprensive Income & Other	-	15	9	-9.8	-22.1	-12.9
Total Common Equity	650	643	608	539.7	470.7	480.8
Shareholders' Equity	650	643	608	539.7	470.7	480.8
Total Liabilities & Equity	1,415	1,333	1,439	983.9	669.1	801.6
Total Debt	438	417	423	116.6	49.1	166.8
Net Cash (Debt)	-344	-364	-391	-76.7	-16.3	-128.1
Net Cash Per Share	-12.40	-13.15	-14.13	-2.77	-0.60	-4.69
Filing Date Shares Outstanding	27.33	27.33	27.33	27.33	27.33	27.33
Total Common Shares Outstanding	27.33	27.33	27.33	27.33	27.33	27.33
Working Capital	497	387	281	154.6	189.6	251.8
Book Value Per Share	23.78	23.53	22.25	19.75	17.22	17.59
Tangible Book Value	234	298	245	281.2	441.3	450.5
Tangible Book Value Per Share	8.56	10.90	8.96	10.29	16.15	16.48
Buildings	-	205	205	428.4	397.6	387.2
Machinery	-	176	159	1,275	1,257	1,236
Construction In Progress	-	-	2	1.4	0.3	2.1

Source: S&P Capital IQ. Standard template. Financial Sources.